Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Alkermes stock (ALKS)

Buy Alkermes stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Alkermes is a drug manufacturers - specialty & generic business based in the US. Alkermes shares (ALKS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $31.78 – an increase of 14.15% over the previous week. Alkermes employs 1,800 staff and has a trailing 12-month revenue of around $1.6 billion.

Our top picks for where to buy Alkermes stock

Top pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you open and fund a new account within 30 days
  • Access to a financial planner
Customer must fund their Active Invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $1,000 is 0.028%. See full terms and conditions.

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, futures and options with as little as $1
  • After-hours trading available
  • Earn 4% interest on uninvested cash with Gold
  • 24/7 customer support

Top pick for advanced trading tools

Go to site
  • Trade stocks, options, futures, currencies, crypto, precious metals and more
  • Mobile, browser and desktop trading platforms
  • Earn 3.83% APY on your uninvested cash

How to buy Alkermes stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ALKS. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Alkermes stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Product Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Offer
SoFi Wealth Management logo
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.01%
Get up to $1,000 in stock when you open and fund a new account. T&C apply.
Trade stocks, ETFs, and options with zero commissions, invest in IPOs or automate your portfolio, with exclusive perks available through SoFi Plus.
Robinhood logo
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures
$0
$0
4%
Get a free stock when you successfully sign up and link your bank account.
Trade stocks, options, crypto and more, with advanced trading tools, fractional shares and exclusive perks for Gold members.
Interactive Brokers logo
Finder score
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex, Treasury Bills, Precious metals
$0
$0
3.83% Lite
4.83% Pro
Trade a wide range of assets, with global market access and pro-grade trading tools.
OPTO logo
Finder score
Stocks, ETFs
$0
$0
4%
Earn up to $300 when you deposit between $2,000–$25,000+.
Copy top-performing portfolios or build your own stock index on Opto's AI-driven thematic investing platform, and get 4% APY on your cash.
JPMorgan logo
Finder score
Mutual funds, ETFs
$0
$25,000
N/A
Get ongoing access to an advisory team with personalized financial planning and expert-built portfolios. Provider terms & conditions apply
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Alkermes stock price (NASDAQ: ALKS)

Use our graph to track the performance of ALKS stocks over time.

Alkermes shares at a glance

Information last updated 2025-04-30.
Latest market close$31.78
52-week range$22.90 - $36.45
50-day moving average $32.09
200-day moving average $29.41
Wall St. target price$39.36
PE ratio 13.0773
Dividend yield N/A
Earnings per share (TTM) $2.20

Is it a good time to buy Alkermes stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Alkermes price performance over time

Historical closes compared with the close of $31.78 from 2025-05-02

1 week (2025-04-23) 17.05%
1 month (2025-04-04) 5.72%
3 months (2025-02-04) 1.53%
6 months (2024-11-04) 19.52%
1 year (2024-05-03) 32.14%
2 years (2023-05-03) 10.92%
3 years (2022-05-03) 9.59%
5 years (2020-05-04) 131.30%

Is Alkermes stock undervalued or overvalued?

Valuing Alkermes stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alkermes's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Alkermes's P/E ratio

Alkermes's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Alkermes shares trade at around 13x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Alkermes's EBITDA

Alkermes's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $449.2 million.

The EBITDA is a measure of a Alkermes's overall financial performance and is widely used to measure a its profitability.

Alkermes financials

Revenue TTM $1.6 billion
Operating margin TTM 37.84%
Gross profit TTM $1.3 billion
Return on assets TTM 12.54%
Return on equity TTM 27.9%
Profit margin 23.57%
Book value $9.03
Market Capitalization $4.7 billion

TTM: trailing 12 months

Alkermes's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Alkermes.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Alkermes's total ESG risk score

Total ESG risk: 28.83

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Alkermes's overall score of 28.83 (as at 12/31/2018) is nothing to write home about – landing it in it in the 53rd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Alkermes is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Alkermes's environmental score

Environmental score: 0.37/100

Alkermes's environmental score of 0.37 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Alkermes is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Alkermes's social score

Social score: 17.49/100

Alkermes's social score of 17.49 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Alkermes is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Alkermes's governance score

Governance score: 8.71/100

Alkermes's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Alkermes is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Alkermes's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Alkermes scored a 1 out of 5 for controversy – the highest score possible, reflecting that Alkermes has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Alkermes Plc was last rated for ESG on: 2019-01-01.

Total ESG score 28.83
Total ESG percentile 53.12
Environmental score 0.37
Environmental score percentile 1
Social score 17.49
Social score percentile 1
Governance score 8.71
Governance score percentile 1
Level of controversy 1

Alkermes share dividends

We're not expecting Alkermes to pay a dividend over the next 12 months.

Have Alkermes's shares ever split?

Alkermes's shares were split on a 2:1 basis on 14 May 2000 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Alkermes shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Alkermes shares which in turn could have impacted Alkermes's share price.

Alkermes share price volatility

Over the last 12 months, Alkermes's shares have ranged in value from as little as $22.9 up to $36.45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alkermes's is 0.348. This would suggest that Alkermes's shares are less volatile than average (for this exchange).

Alkermes overview

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N. V. , Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International.

Frequently asked questions

null
What percentage of Alkermes is owned by insiders or institutions?
Currently 1.484% of Alkermes shares are held by insiders and 104.88% by institutions.
How many people work for Alkermes?
Latest data suggests 1,800 work at Alkermes.
When does the fiscal year end for Alkermes?
Alkermes's fiscal year ends in December.
Where is Alkermes based?
Alkermes's address is: Connaught House, Dublin, Ireland, D04 C5Y6
What is Alkermes's ISIN number?
Alkermes's international securities identification number is: USG017671052
What is Alkermes's CUSIP number?
Alkermes's Committee on Uniform Securities Identification Procedures number is: 01642T108

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

More guides on Finder

Go to site